Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Anti–influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface
Jinhui Dong, Iuliia Gilchuk, Sheng Li, Ryan Irving, Matthew T. Goff, Hannah L. Turner, Andrew B. Ward, Robert H. Carnahan, James E. Crowe Jr.
Jinhui Dong, Iuliia Gilchuk, Sheng Li, Ryan Irving, Matthew T. Goff, Hannah L. Turner, Andrew B. Ward, Robert H. Carnahan, James E. Crowe Jr.
View: Text | PDF
Concise Communication Immunology Infectious disease

Anti–influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface

  • Text
  • PDF
Abstract

Although broadly protective, stem-targeted Abs against the influenza A virus hemagglutinin (HA) have been well studied, very limited information is available on Abs that broadly recognize the head domain. We determined the crystal structure of the HA protein of the avian H7N9 influenza virus in complex with a pan-H7, non-neutralizing, protective human Ab. The structure revealed a B cell epitope in the HA head domain trimer interface (TI). This discovery of a second major protective TI epitope supports a model in which uncleaved HA trimers exist on the surface of infected cells in a highly dynamic state that exposes hidden HA head domain features.

Authors

Jinhui Dong, Iuliia Gilchuk, Sheng Li, Ryan Irving, Matthew T. Goff, Hannah L. Turner, Andrew B. Ward, Robert H. Carnahan, James E. Crowe Jr.

×

Figure 3

Crystal structure and detailed interactions between Fab H7-200 and H7N9 SH13 HA1.

Options: View larger image (or click on image) Download as PowerPoint
Crystal structure and detailed interactions between Fab H7-200 and H7N9 ...
All protein components of the Ab-Ag complex are shown in a cartoon representation. The HA1 domain is shown in green, the H7-200 Fab heavy chain in cyan, and the light chain in magenta. (A) Individual CDRs of Fab H7-200, together with the influenza HA1 190 helix of HA1, are labeled. Left and right panels show side and top views of the complex structure. Principal and secondary antigenic sites are indicated with yellow ovals. (B) The principal antigenic site on H7N9 HA recognized by Fab H7-200, including residues Q163, N199–L201, and N208–S216, interacts with the Fab H7-200 heavy-chain strands C′ and C′′, CDRH2, CDRH3, CDRH1, and CDRL3. Residues involved in the Ab-Ag interaction are shown in stick representation. Hydrogen bonds are represented by dashed yellow lines. H7N9 HA residues are labeled in black, residues from Fab H7-200 heavy chain in red, and those from the light chain in blue. Fab H7-200 residues were numbered using the Kabat numbering system. (C) The secondary antigenic site on H7N9 HA recognized by Fab H7-200, consisting of residues K101, V103, I182, H184, D231, and H233, interacts with the tip of the CDRH3 loop of Fab H7-200. (D) Sequence alignment of antigenic sites of several major H7 influenza and H15N9 viruses recognized by Fab H7-200 and H1N1, H3N2, H5N1, and H10N8 viruses. Antigenic residues are highlighted with brown rectangles, and important residues for Ab-Ag binding in the crystal structure of the Ab-Ag complex are marked with red bars. The first residues of the sequence segments are numbered. Sequence alignment was performed with the multiple sequence alignment software Muscle (17), and the alignment figure was made with the sequence alignment editing software Aline (18).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts